CollPlant Biotechnologies Ltd. ( CLGN) - Key Metrics
CLGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.01 | -$0.27 | -$0.23 | -$0.23 |
| 2025Q2 | $0.02 | -$0.28 | -$0.21 | -$0.21 |
| 2025Q1 | $0.18 | -$0.13 | -$0.10 | -$0.10 |
CLGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -2.46 |
| 2025Q2 | ? | -1.20 |
| 2025Q1 | ? | -5.09 |
CLGN
Price: $0.34
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 28000
Market Capitalization: 4.8 million